AKT1 and malignant colon neoplasm: Importantly, the growth factor-dependent induction of TCTP protein expression levels in HT-29 cells could be dramatically reduced by pharmacological inhibition of AKT, which indicates that TCTP synthesis is regulated by the AKT pathway in BRAF mutated HT-29 colon cancer cells [31].